title: [Cerebral toxoplasmosis in AIDS: efficacy and good tolerance of cotrimoxazole].
authors.forename: D
authors.initials: D
authors.lastname: Smadja
authors.forename: L
authors.initials: L
authors.lastname: Lin
authors.forename: E
authors.initials: E
authors.lastname: Cidolit
authors.forename: C
authors.initials: C
authors.lastname: Neisson-Vernant
authors.forename: P
authors.initials: P
authors.lastname: Cabre
authors.forename: J C
authors.initials: JC
authors.lastname: Vernant
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D014057:Tomography, X-Ray Computed; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D015662:Trimethoprim, Sulfamethoxazole Drug Combination
vernacular_title: Toxoplasmose cérébrale au cours du SIDA: efficacité et bonne tolérance du cotrimoxazole.